{"id":14711,"date":"2026-08-24T14:53:00","date_gmt":"2026-08-24T19:53:00","guid":{"rendered":"https:\/\/shockwavemedical.com\/?p=14711"},"modified":"2026-08-24T14:53:05","modified_gmt":"2026-08-24T19:53:05","slug":"advancing-care-for-angina-with-shockwave-reducer","status":"publish","type":"post","link":"https:\/\/shockwavemedical.com\/en-eu\/education\/advancing-care-for-angina-with-shockwave-reducer\/","title":{"rendered":"Evidence in Action: Advancing Care for Angina with Shockwave Reducer"},"content":{"rendered":"\n<section id=\"block_246e8db417d66f0c0c35948db4afb113\" class=\"block block--wysiwyg wysiwyg_styles u-bgColorNone shockwave container\">\n\t<div class=\"u-wysiwyg u-animation\">\n\t\t<p>At EuroPCR 2026, anchorperson Rasha Al-Lamee, spokesperson Tommaso Gori, and discussants Ranil de Silva, Oriol Rodriguez Leor, Mariusz Tomaniak, and Mike Foley took the stage to present \u201cEvidence in Action: Advancing Care for Angina with <a href=\"https:\/\/www.shockwavemedical.com\/en-eu\/products\/shockwave-reducer\/\">Shockwave Reducer<\/a>\u201d<\/p>\n<p><strong>Speakers:\u00a0<\/strong><\/p>\n<ul>\n<li>Dr. Ranil de Silva \u2013 Royal Brompton Hospital, London<\/li>\n<li>Dr. Oriol Rodriguez Leor \u2013 Hospital Universitari Germans Trias i Pujol, Barcelona<\/li>\n<li>Prof. Mariusz Tomaniak \u2013 Medical University of Warsaw, Warsaw<\/li>\n<li>Dr. Mike Foley \u2013 Imperial College Healthcare NHS Trust, London<\/li>\n<\/ul>\n<p>\u00a0<\/p>\n<h3 id=\"prevalence\">The True Prevalence and Impact of Angina<\/h3>\n<p>Dr. Ranil de Silva provides an overview of the definition, prevalence, challenges and impact of refractory angina on patients\u2019 lives and healthcare systems. He describes the spectrum of angina patients and the types of therapies that may be most appropriate to meet their needs.<\/p>\n<div class=\"video\"><iframe title=\"YouTube video player\" src=\"https:\/\/www.youtube.com\/embed\/RZ5J0MsFRvA?si=0pu59IOrwwfVcHgb\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><span data-mce-type=\"bookmark\" style=\"display: inline-block; width: 0px; overflow: hidden; line-height: 0;\" class=\"mce_SELRES_start\">\ufeff<\/span><\/iframe><\/div>\n<h3 id=\"obstructive\">Current and Future Clinical Data Supporting the Use of the Shockwave Reducer in Obstructive Disease<\/h3>\n<p>Tune in to watch Dr. Oriol Rodriguez Leor review the clinical evidence from multiple Shockwave Reducer studies. He covers the existing evidence for obstructive disease as well as the consistency in results across procedural success, safety, and multiple measures of quality of life. He also highlights important ongoing studies and their potential future impact on the understanding and treatment of angina.<\/p>\n<div class=\"video\"><iframe title=\"YouTube video player\" src=\"https:\/\/www.youtube.com\/embed\/9mEadLNKXUk?si=5pSH25UmYoH05hdd\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/div>\n<h3 id=\"non-obstructive\">Current and Future Clinical Data Supporting the Use of the Shockwave Reducer in Non-Obstructive Disease<\/h3>\n<p>Join Prof. Mariusz Tomaniak as he explores the growing importance of treating angina in patients with non-obstructive disease via a case study. He then reviews the latest clinical results on Shockwave Reducer use in non-obstructive coronary arteries (ANOCA)\/ischemia with no obstructive coronary arteries (INOCA) patients. He also discusses the upcoming results from ongoing trials which will provide significant clinical and mechanistic insights for this undertreated patient group.<\/p>\n<div class=\"video\"><iframe title=\"YouTube video player\" src=\"https:\/\/www.youtube.com\/embed\/nHEsM_FaGng?si=GsyF5rHkQTEBD3Mn\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/div>\n<h3 id=\"reducer\">Shockwave Reducer\u2019s Unique <a href=\"https:\/\/www.shockwavemedical.com\/en-eu\/reducer-overview-moa\/\">Mechanism of Action<\/a> and clinical impact on patients with angina<\/h3>\n<p>Dr. Mike Foley reviews the hypothesized MOA of the Shockwave Reducer device and the mechanistic insights drawn from the ORBITA-COSMIC clinical study. Additionally, he provides details on the clinical and real-life quality of life changes potentially made possible with Shockwave Reducer.<\/p>\n<div class=\"video\"><iframe title=\"YouTube video player\" src=\"https:\/\/www.youtube.com\/embed\/a2t1_0uVKi8?si=RRxl0CCFXW5boA0c\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/div>\n<div><\/div>\n<hr \/>\n<p><span class=\"legal_copy\">Individual patient stories. Results may vary.<\/span><\/p>\n<p><span class=\"legal_copy\">The physicians featured are paid consultants of Shockwave Medical. Views expressed are those of the authors and not necessarily those of Shockwave Medical.<\/span><\/p>\n<p><span class=\"legal_copy\">Shockwave Reducer is commercially available in select European countries and has been implanted in over 3,500 patients. It is currently under clinical investigation in the U.S.<\/span><\/p>\n<p><span class=\"legal_copy\">CAUTION:\u202fIn the United States, Shockwave Reducer is an investigational device, limited by United States law to investigational use. Shockwave Reducer is subject of investigational testing and is being studied in the COSIRA-II trial in Canada. Shockwave Reducer is commercially available in certain countries outside the U.S. and Canada. Please contact your local representative for specific country availability. Prior to use, please reference the Instructions for Use for more information on warnings, precautions and adverse events: <a href=\"http:\/\/ifu.sw-reducer.com\" target=\"_blank\" rel=\"noopener\">ifu.sw-reducer.com<\/a><\/span><\/p>\n\t<\/div>\n\t\t\t<div class=\"button-container\">\n\t\t\t\n<a data-atom=\"button\" class=\"optional-button btn--primary\" href=\"https:\/\/shockwavemedical.com\/en-eu\/products\/shockwave-reducer\/\" target=\"_self\" aria-label=\"Explore Shockwave Reducer - link to page\">Explore Shockwave Reducer<i aria-hidden=\"true\" class=\"fa-sharp fa-arrow-right fa-solid\"><\/i><\/a>\t\t<\/div>\n\t<\/section>","protected":false},"excerpt":{"rendered":"<p>At EuroPCR 2026, leading experts in interventional cardiology came together to discuss the growing evidence supporting Shockwave Reducer<\/p>\n","protected":false},"author":19,"featured_media":14708,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":[204],"meta":{"_acf_changed":false,"content-type":"","footnotes":""},"categories":[17],"tags":[],"disease-state":[179],"education-topic":[191,195],"product-tag":[287],"specialty":[328],"technology":[320],"class_list":["post-14711","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized-en-uk","disease-state-refractory-angina-en-uk","education-topic-mechanism-of-action-moa","education-topic-peer-to-peer-en-uk","format-video-en-uk","product-tag-shockwave-reducer-en-uk","specialty-interventional-cardiologists-en-uk","technology-coronary-sinus-reduction-en-uk"],"acf":[],"_links":{"self":[{"href":"https:\/\/shockwavemedical.com\/en-eu\/wp-json\/wp\/v2\/posts\/14711","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/shockwavemedical.com\/en-eu\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/shockwavemedical.com\/en-eu\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/shockwavemedical.com\/en-eu\/wp-json\/wp\/v2\/users\/19"}],"replies":[{"embeddable":true,"href":"https:\/\/shockwavemedical.com\/en-eu\/wp-json\/wp\/v2\/comments?post=14711"}],"version-history":[{"count":1,"href":"https:\/\/shockwavemedical.com\/en-eu\/wp-json\/wp\/v2\/posts\/14711\/revisions"}],"predecessor-version":[{"id":14712,"href":"https:\/\/shockwavemedical.com\/en-eu\/wp-json\/wp\/v2\/posts\/14711\/revisions\/14712"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/shockwavemedical.com\/en-eu\/wp-json\/wp\/v2\/media\/14708"}],"wp:attachment":[{"href":"https:\/\/shockwavemedical.com\/en-eu\/wp-json\/wp\/v2\/media?parent=14711"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/shockwavemedical.com\/en-eu\/wp-json\/wp\/v2\/categories?post=14711"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/shockwavemedical.com\/en-eu\/wp-json\/wp\/v2\/tags?post=14711"},{"taxonomy":"disease-state","embeddable":true,"href":"https:\/\/shockwavemedical.com\/en-eu\/wp-json\/wp\/v2\/disease-state?post=14711"},{"taxonomy":"education-topic","embeddable":true,"href":"https:\/\/shockwavemedical.com\/en-eu\/wp-json\/wp\/v2\/education-topic?post=14711"},{"taxonomy":"format","embeddable":true,"href":"https:\/\/shockwavemedical.com\/en-eu\/wp-json\/wp\/v2\/format?post=14711"},{"taxonomy":"product-tag","embeddable":true,"href":"https:\/\/shockwavemedical.com\/en-eu\/wp-json\/wp\/v2\/product-tag?post=14711"},{"taxonomy":"specialty","embeddable":true,"href":"https:\/\/shockwavemedical.com\/en-eu\/wp-json\/wp\/v2\/specialty?post=14711"},{"taxonomy":"technology","embeddable":true,"href":"https:\/\/shockwavemedical.com\/en-eu\/wp-json\/wp\/v2\/technology?post=14711"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}